This past year was not only full of important milestones, but it was also a year of celebration as we marked our 80th anniversary! Each achievement in 2024 has built on our 80-year legacy, taking us closer to our mission of transforming medical dermatology with innovative solutions. Everything we have achieved has been possible thanks to our invaluable teams and partners, whose dedication continually enriches our heritage. As we look ahead to 2025, we remain dedicated to improving skin health and pioneering solutions for future generations. #2024Highlights #WeAreAlmirall
Almirall’s Post
More Relevant Posts
-
Renewal and re-enrollment season might seem like a distant memory, but teams should start preparing for next year's #blizzardseason as soon as possible. In a recent issue of Biologic Coordinators of Dermatology (BCoD)'s Access Dermatology Magazine, we propose a few tips you can use to prepare for renewal season... and how technology can help. Check out the article below, or reach out to learn how RxLightning can help streamline your re-enrollment processes and remove paper/phone/fax from your workflow!
To view or add a comment, sign in
-
We've collaborated with @MediaPlanet to bring you our article on ‘Managing Psoriasis Under The Sun With Sunwise Practices’ as part of the Innovations in Dermatology campaign. Learn more about key considerations when exposing your skin to the sun. Explore the article online at https://ow.ly/E92g50SmtJg and pick up a copy within today’s The Guardian. #InnovationsInDermatology #PsoriasisTips #PsoriasisManagement #PsoriasisAwareness
To view or add a comment, sign in
-
-
Have you seen the International Psoriasis Council report on #psoriasis coverage at the American Academy of Dermatology Annual Meeting 2024? Read our summary of key topics here: https://loom.ly/QIxSpfE #AAD2024
To view or add a comment, sign in
-
-
By Spring 2025, the Digital Dermatology technology aims to be adopted as standard practice across Scotland, to contribute to reduced waiting times and improved patient outcomes. For the full story, visit ➡ https://lnkd.in/eyeg8giR
To view or add a comment, sign in
-
-
May is skin cancer month and here are a few tips and explanations from Laura Jordan, DO from Dermatology Partners. https://lnkd.in/gangZN_G #magruderhospital #improvinglivestogether #ottawacountyhealthcare
To view or add a comment, sign in
-
-
🚀Station F, Grandes Tendances de la E-Santé event ! 🗓️28th of January 2025 💡#AI in aesthetic dermatology 💡#personalized care through AI and a big Data 💡#Ethical considerations & global guidelines 💡#Futureperspectives #SDS Summit
To view or add a comment, sign in
-
-
A behind-the-scenes look at Castle's #dermatology lab process, where we process DecisionDx-Melanoma, DecisionDx-SCC, and MyPath Melanoma tests...
Want to know what the dermatology lab process looks like at Castle? Join us for a behind-the-scenes tour of our Phoenix laboratory, and follow along from sample receipt to the generation of a test report. Empowering people. Informing care decisions. #DecisionDxMelanoma #DecisionDxSCC #MyPathMelanoma
To view or add a comment, sign in
-
What are the limitations of current dermatology research approaches? How does a regenerative medicine-based approach differ from conventional treatments for skin diseases and wound healing? Find out what industry experts think in this Ask the Experts feature, sponsored by PromoCell >>> https://hubs.ly/Q02YK68g0
To view or add a comment, sign in
-
What are the limitations of current dermatology research approaches? How does a regenerative medicine-based approach differ from conventional treatments for skin diseases and wound healing? Find out what industry experts think in this Ask the Experts feature, sponsored by PromoCell >>> https://hubs.ly/Q02TdDD10
To view or add a comment, sign in
-
🌟 As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year. From innovative studies to analyses of real-world patient experiences, review more below. ⬇️ https://lnkd.in/gAGGxaFn
To view or add a comment, sign in
-